Platelet Glycoprotein IIb IIIa Receptor Antagonists


  • Abciximab (ReoPro) (see Abciximab, [[Abciximab]])
  • Eptifibatide (Integrilin) (see Eptifibatide, [[Eptifibatide]])
  • Tirofiban (Aggrastat) (see Tirofiban, [[Tirofiban]])


  • Platelet Glycoprotein IIb/IIIa Receptor Antagonist


  • Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: A nemesis of platelet glycoprotein IIb/iIIa inhibitors. Catheterization and Cardiovascular Interventions Volume 49, Issue 2, pages 181–184, February 2000
  • Alveolar Hemorrhage: An Underdiagnosed Complication of Treatment with Glycoprotein IIb/IIIa Inhibitors. Journal of Interventional Cardiology Volume 19, Issue 4, pages 356–363, August 2006
  • Moll S, Poepping I, Hauck S, et al. Pseudothrombocytopenia after abciximab (Reopro) treatment. Circulation 1999; 100:1460
  • Dasgupta H, Blankenship J, Wood G, et al. Thrombocytopenia complicating treatment with intravenous IIb/IIIa receptor inhibitors: a pooled analysis. Am Heart J 2000; 140:206-211